SURVIVAL ANALYSIS AND PREDICTORS OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE IN CLINICAL COMPLETE-RESPONDERS AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER

被引：0
|
作者：
Vila-Reyes, Helena
Lee, Kevin
Decastro, G. Joel
Li, Gen
Haas, Christopher R.
Pak, Jamie S.
Faiena, Izak
Anderson, Christopher B.
McKiernan, James M.
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD60-04
引用
收藏
页码：E1274 / E1274
页数：1
相关论文
共 50 条
  • [31] Role of neoadjuvant chemotherapy in muscle-invasive bladder cancer: Clinical and cost effectiveness
    Goonewardene, Sanchia S.
    Bahl, Amit
    Persad, Raj
    JOURNAL OF CLINICAL UROLOGY, 2015, 8 (04) : 279 - 284
  • [32] NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER: DIFFERENCES IN CLINICAL AND PATHOLOGICAL RESPONCE
    Galosi, Andrea Benedetto
    Milanese, Giulio
    Giustini, Lucio
    Sbrollini, Giulia
    Chiodega, Isabella
    Maselli, Guevar
    Burattini, Luciano
    Berardi, Rossana
    Montironi, Rodolfo
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1194 - E1195
  • [33] Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Pak, Jamie S.
    Haas, Christopher R.
    Anderson, Christopher B.
    DeCastro, G. Joel
    Benson, Mitchell C.
    McKiernan, James M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (11) : 787.e9 - 787.e15
  • [34] Bladder cancer susceptibility polymorphisms and mortality from non-muscle and muscle-invasive bladder cancer.
    Leeming, Reno C.
    Zens, Michael S.
    Seigne, John D.
    Christensen, Brock C.
    Gilbert-Diamond, Diane
    Karagas, Margaret R.
    Passarelli, Michael N.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 54 - 55
  • [35] Utilization and predictors of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the Veterans Health Administration
    Sandhu, Gurdarshan Singh
    Luo, Suhong
    Zeringue, Angelique
    Carson, Kenneth Robert
    Nepple, Kenneth Gerard
    Strope, Seth A.
    Hudson, M'Liss A.
    Grubb, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] NEOADJUVANT CHEMOTHERAPY IN MUSCLE INVASIVE BLADDER CANCER
    Hazhir, Samad
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A54 - A54
  • [37] Neoadjuvant chemotherapy in muscle invasive bladder cancer
    Suer, Evren
    Turkolmez, Kadir
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (01): : 74 - 78
  • [38] Analysis of neoadjuvant immunotherapy and chemotherapy for muscle-invasive bladder cancer in a national registry
    Klein, Matthew Nicholas
    Xu, Vincent Eric
    Gordon, Olivia French
    Antar, Ryan Michael
    Whalen, Michael Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 611 - 611
  • [39] COST EFFECTIVENESS ANALYSIS OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
    Stevenson, Scott
    Deibert, Chris
    McKiernan, James
    JOURNAL OF UROLOGY, 2013, 189 (04): : E170 - E170
  • [40] NEOADJUVANT VERSUS ADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: A DECISION ANALYSIS
    Afferi, Luca
    Jahn, Beate
    Fankhauser, Christian D.
    Cathomas, Richard
    Bellmunt, Joaquim
    Moschini, Marco
    Mattei, Agostino
    Chang, Steven L.
    Siebert, Uwe
    JOURNAL OF UROLOGY, 2024, 211 (05): : E863 - E864
12345